Perimeter Medical Imaging Q4 2024 Earnings Conference Call:
On March 27, 2025, at 5:00 PM ET, Perimeter Medical Imaging AI, Inc. (OTCPK: PYNKF) held its Q4 2024 earnings conference call. The call was led by the company’s IR, Stephen Kilmer, CFO, Sara Brien, and CEO, Adrian Mendes. Participating on the analyst side were Michael Freeman from Raymond James and Scott McAuley from Paradigm Capital.
Company Participants:
- Stephen Kilmer – IR
- Sara Brien – CFO
- Adrian Mendes – CEO
Conference Call Participants:
- Michael Freeman – Raymond James
- Scott McAuley – Paradigm Capital
During the call, the company provided an update on their financial results for the fourth quarter of 2024. They reported a revenue of $5.2 million, a decrease from the $6.5 million reported in the same quarter the previous year. This decrease was primarily due to lower sales of their OCT (Optical Coherence Tomography) systems and consumables. The company also reported a net loss of $11.1 million for the quarter, compared to a net loss of $9.3 million in the same quarter the previous year.
Despite the financial results, the company expressed optimism about their future prospects. They highlighted the launch of their new OCT system, the PIONEER, which they believe will help drive growth in the coming quarters. The PIONEER system is designed to provide real-time, high-definition imaging for surgical planning and guidance in breast cancer procedures. The company also announced that they have received FDA clearance for the system and have already received orders from several key customers.
Impact on Individual Investors:
The financial results reported by Perimeter Medical Imaging in their Q4 2024 earnings call may have a negative impact on individual investors holding shares of the company. The decrease in revenue and increase in net loss may cause the stock price to decline. However, the company’s optimism about the future prospects of their new OCT system, the PIONEER, may help mitigate some of the negative sentiment. It’s important for individual investors to closely monitor the company’s financial performance and regulatory developments in the coming quarters.
Impact on the World:
The development and commercialization of advanced medical imaging technologies, such as Perimeter Medical Imaging’s OCT systems, can have a significant impact on the healthcare industry and the world at large. These technologies can help improve the accuracy and efficiency of surgical procedures, leading to better patient outcomes and reduced healthcare costs. In the case of breast cancer, the use of real-time, high-definition imaging during surgical procedures can help ensure that all cancerous tissue is removed while minimizing the risk of unnecessary surgery. This can lead to improved patient quality of life and reduced healthcare costs associated with repeat surgeries and long-term care.
Conclusion:
Perimeter Medical Imaging AI, Inc.’s Q4 2024 earnings call provided an update on the company’s financial results and highlighted the launch of their new OCT system, the PIONEER. The financial results reported were lower than the same quarter the previous year, primarily due to lower sales of their OCT systems and consumables. However, the company expressed optimism about the future prospects of the PIONEER system and announced that they have received FDA clearance and several orders from key customers. The impact of these developments on individual investors and the world at large will depend on the company’s ability to drive growth and successfully commercialize the PIONEER system.
